FACTBOX-Vaccines delivered under COVAX sharing scheme for poorer countries

(Updates with Chad, Libya) June 25 (Reuters) - The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), aims to secure 2 billion vaccine doses for lower-income countries by the end of 2021. The following tables list countries that have received vaccines under the scheme, sorted by region and latest delivery: AFRICA & MIDDLE EAST COUNTRY LATEST DATE VACCINE TYPE POPULATION TOTAL DELIVERY DELIVERED Ivory Coast 504,000 Feb. 26 AstraZeneca/Oxford 26 million 504,000 Nigeria 3.9 million March 2 AstraZeneca/Oxford 201 million 3.9 million Democratic 1.7 million March 2 AstraZeneca/Oxford 87 million 1.7 million Republic of Congo Gambia 36,000 March 2 AstraZeneca/Oxford 2.3 million 36,000 Kenya 1 million March 3 AstraZeneca/Oxford 53 million 1 million Sudan 828,000 March 3 AstraZeneca/Oxford 43 million 828,000 Sao Tome and 24,000 March 3 AstraZeneca/Oxford 215,000 24,000 Principe Mali 396,000 March 4 AstraZeneca/Oxford 20 million 396,000 Malawi 360,000 March 5 AstraZeneca/Oxford 19 million 360,000 Liberia 96,000 March 5 AstraZeneca/Oxford 4.9 million 96,000 Djibouti 24,000 March 6 AstraZeneca/Oxford 990,000 24,000 Ethiopia 2.2 million March 7 AstraZeneca/Oxford 112 million 2.2 million Mozambique 384,000 March 8 AstraZeneca/Oxford 30 million 384,000 Sierra Leone 96,000 March 8 AstraZeneca/Oxford 7.8 million 96,000 Benin 144,000 March 10 AstraZeneca/Oxford 12 million 144,000 Cape Verde 24,000 March 12 AstraZeneca/Oxford 540,000 24,000 Somalia 300,000 March 15 AstraZeneca/Oxford 15 million 300,000 Lebanon 33,600 March 24 AstraZeneca/Oxford 6.9 million 33,600 South Sudan 132,000 March 25 AstraZeneca/Oxford 11 million 132,000 Iraq 336,000 March 25 AstraZeneca/Oxford 39 million 336,000 Yemen 360,000 March 31 AstraZeneca/Oxford 29 million 360,000 Algeria 364,800 April 3 AstraZeneca/Oxford 43 million 364,800 Guinea 194,400 April 11 AstraZeneca/Oxford 13 million 194,400 Zambia 228,000 April 12 AstraZeneca/Oxford 18 million 228,000 Comoros Islands 12,000 April 12 AstraZeneca/Oxford 851,000 12,000 Guinea-Bissau 28,800 April 13 AstraZeneca/Oxford 1.9 million 28,800 Niger 355,000 April 14 AstraZeneca/Oxford 23 million 355,000 Cameroon 391,200 April 18 AstraZeneca/Oxford 25.9 million 391,200 Syria 256,800 April 22 AstraZeneca/Oxford 17 million 256,800 Mauritania 31,200 April 26 AstraZeneca/Oxford 4.5 million 100,700 Ghana 350,000 May 7 AstraZeneca/Oxford 30 million 950,000 Egypt 1.7 million May 13 AstraZeneca/Oxford 100 million 2.6 million Namibia 43,000 May 24 AstraZeneca/Oxford 2.5 million 67,000 Palestinian 102,960 May 25 Pfizer/BioNTech 4.7 million 164,400 Territories Rwanda 247,000 May 28 AstraZeneca/Oxford 13 million 589,960 Tunisia 253,890 May 28 Pfizer/BioNTech 12 million 604,290 Togo 50,310 May 29 Pfizer/BioNTech 8.1 million 206,310 Botswana 38,400 May 29 AstraZeneca/Oxford 2.3 million 38,400 Burkina Faso 115,000 May 30 AstraZeneca/Oxford 20 million 115,000 Lesotho 36,000 May 31 AstraZeneca/Oxford 2.1 million 72,000 Angola 100,620 June 1 Pfizer/BioNTech 32 million 724,620 Jordan 146,400 June 3 AstraZeneca/Oxford 10 million 436,800 Senegal 184,000 June 3 AstraZeneca/Oxford 16 million 508,000 Eswatini 14,400 June 9 AstraZeneca/Oxford 1.1 million 26,400 Uganda 175,200 June 16 AstraZeneca/Oxford 44 million 1.0 million Chad 100,620 June 23 Pfizer/BioNTech 15.9 million 100,620 Libya 54,600 June 24 Pfizer/BioNTech 6.8 million 229,800 EUROPE COUNTRY LATEST DATE VACCINE TYPE POPULATION TOTAL DELIVERY DELIVERED Georgia 43,200 March 13 AstraZeneca/Oxford 3.7 million 43,200 Montenegro 24,000 March 28 AstraZeneca/Oxford 622,000 24,000 Azerbaijan 84,000 April 4 AstraZeneca/Oxford 10 million 84,000 Bosnia 32,760 May 10 Pfizer/BioNTech 3.3 million 82,560 Serbia 120,000 May 12 AstraZeneca/Oxford 6.9 million 177,600 North 38,400 May 14 AstraZeneca/Oxford 2.1 million 62,400 Macedonia Armenia 50,000 May 17 AstraZeneca/Oxford 3.0 million 74,000 Kosovo 100,620 May 27 Pfizer/BioNTech 1.8 million 163,020 Albania 40,800 June 2 AstraZeneca/Oxford 2.9 million 120,000 Ukraine 705,600 June 3 AstraZeneca/Oxford 44 million 1.3 million Moldova 45,600 June 4 AstraZeneca/Oxford 2.7 million 191,820 ASIA & PACIFIC COUNTRY LATEST DATE VACCINE TYPE POPULATION TOTAL DELIVERY DELIVERED Cambodia 324,000 March 2 AstraZeneca/Oxford 16 million 324,000 Nepal 348,000 March 7 AstraZeneca/Oxford 29 million 348,000 Maldives 12,000 March 7 AstraZeneca/Oxford 531,000 12,000 Sri Lanka 264,000 March 7 AstraZeneca/Oxford 22 million 264,000 Afghanistan 468,000 March 8 AstraZeneca/Oxford 38 million 468,000 Tajikistan 192,000 March 9 AstraZeneca/Oxford 9.3 million 192,000 Uzbekistan 660,000 March 17 AstraZeneca/Oxford 34 million 660,000 Tonga 24,000 March 31 AstraZeneca/Oxford 105,000 24,000 Nauru 7,200 April 2 AstraZeneca/Oxford 12,600 7,200 Brunei 24,000 April 2 AstraZeneca/Oxford 433,000 24,000 Tuvalu 4,800 April 8 AstraZeneca/Oxford 11,600 4,800 Samoa 24,000 April 9 AstraZeneca/Oxford 197,000 24,000 Fiji 10,000 May 6 AstraZeneca/Oxford 900,000 46,000 Madagascar 250,000 May 8 AstraZeneca/Oxford 27 million 250,000 Vietnam 1.7 May 16 AstraZeneca/Oxford 96 million 2.5 million million Vanuatu 24,000 May 19 AstraZeneca/Oxford 300,000 24,000 Malaysia 559,200 May 21 AstraZeneca/Oxford 32 million 828,000 Kiribati 24,000 May 25 AstraZeneca/Oxford 118,000 24,000 Mongolia 100,620 May 27 Pfizer/BioNTech 3.2 million 191,120 Pakistan 100,000 May 28 Pfizer/BioNTech 217 million 1.3 million Bangladesh 106,000 June 1 Pfizer/BioNTech 163 million 106,000 Laos 100,620 June 2 Pfizer/BioNTech 7.2 million 232,620 Timor-Leste 100,800 June 9 AstraZeneca/Oxford 1.3 million 124,800 Philippines 2.3 June 10 Pfizer/BioNTech 108 million 5.0 million million Indonesia 1.5 June 10 AstraZeneca/Oxford 271 million 8.2 million million Papua New 146,000 June 15 AstraZeneca/Oxford 8.8 million 278,000 Guinea Solomon 28,800 June 19 AstraZeneca/Oxford 670,000 52,800 Islands AMERICAS COUNTRY LATEST DATE VACCINE TYPE POPULATION TOTAL DELIVERY DELIVERED Nicaragua 135,000 March 16 AstraZeneca/Oxford 6.5 million 135,000 Dominica 28,800 April 6 AstraZeneca/Oxford 72,000 28,800 Bermuda 9,600 April 6 AstraZeneca/Oxford 64,000 9,600 Saint Kitts 21,600 April 7 AstraZeneca/Oxford 53,000 21,600 and Nevis Argentina 864,000 April 18 AstraZeneca/Oxford 45 million 1,082,000 Brazil 4.0 May 2 AstraZeneca/Oxford 211 million 5.0 million million Guyana 38,400 May 10 AstraZeneca/Oxford 783,000 62,400 Trinidad and 33,600 May 10 AstraZeneca/Oxford 1.4 million 67,600 Tobago Suriname 28,800 May 10 AstraZeneca/Oxford 581,000 52,800 Barbados 33,600 May 11 AstraZeneca/Oxford 287,000 67,200 Bahamas 33,600 May 11 AstraZeneca/Oxford 390,000 33,600 Panama 74,400 May 11 AstraZeneca/Oxford 4.2 million 74,400 Saint Lucia 26,400 May 12 AstraZeneca/Oxford 183,000 50,400 Belize 33,600 May 12 AstraZeneca/Oxford 390,000 67,200 Costa Rica 88,800 May 13 AstraZeneca/Oxford 5.0 million 132,000 Dominican 187,200 May 14 AstraZeneca/Oxford 10.7 million 278,400 Republic Uruguay 50,400 May 14 AstraZeneca/Oxford 3.5 million 98,400 Chile 331,000 May 20 AstraZeneca/Oxford 19 million 489,400 El Salvador 96,000 May 25 AstraZeneca/Oxford 6.5 million 383,880 Saint 21,600 May 25 AstraZeneca/Oxford 111,000 45,600 Vincent and the Grenadines Bolivia 100,620 May 26 Pfizer/BioNTech 12 million 421,050 Grenada 21,600 May 26 AstraZeneca/Oxford 112,000 45,600 Mexico 2.2 May 27 AstraZeneca/Oxford 128 million 3.3 million million Peru 511,200 May 29 AstraZeneca/Oxford 33 million 904,200 Jamaica 55,200 May 30 AstraZeneca/Oxford 2.9 million 124,800 Colombia 909,600 June 3 AstraZeneca/Oxford 50 million 3.3 million Guatemala 321,600 June 3 AstraZeneca/Oxford 17 million 724,800 Paraguay 134,400 June 3 AstraZeneca/Oxford 7.0 million 304,400 Antigua and 16,800 June 9 AstraZeneca/Oxford 97,000 40,800 Barbuda Ecuador 336,000 June 11 AstraZeneca/Oxford 17 million 756,000 Honduras 117,000 June 17 Pfizer/BioNTech 9.7 million 354,600 Sources: WHO, UNICEF, GAVI, releases from local authorities (Reporting by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou in Gdansk; Editing by Milla Nissi, Mark Heinrich and Mark Potter)

06/25/2021 13:02

News, Photo and Web Search